Basil Sharrack News Today

Researchers maintain that patients with severe multiple sclerosis should be able to receive autologous hematopoietic stem cell transplantation as a first-line therapy.

After a cutting-edge new treatment, Colette Edwards' MS came to a complete halt. Six years on, she says she still has no active disease